Katherine Leibowitz Speaking at MAGI Cloud Conference on How COVID-19 Is Changing Clinical Trial Agreements

We are pleased to announce that Katherine Leibowitz will be giving a talk on “How COVID-19 Is Changing Clinical Trial Agreements” at the upcoming MAGI Clinical Research Cloud Conference 2020.  The virtual event runs from June 22 – July 2, 2020.  We have previously written about the impact of COVID-19 on clinical trial agreements.

Katherine’s session is on July 2nd from 1 – 2 p.m. and will include both the sponsor and site perspectives.  The last 20 minutes will be a live Q&A session during which she and her co-presenter, Conor Flynn from SUNY Buffalo, can answer your questions about these important issues directly.

Katherine will also be chairing the session on “CTAs for Investigator-Initiated Trials” and will moderate the Q&A. The investigator-initiated trials session is on June 22nd from 4 – 5 p.m.

This is MAGI’S first virtual event, and it will be a shortened version of the cancelled Philadelphia conference from April (where Katherine was also supposed to speak).  You can access the program agenda here.


This contents of this alert should not be construed as legal advice or a legal opinion on any specific facts or circumstances. This content is not intended to and does not, by its receipt, create an attorney-client relationship. The contents are intended for general informational purposes only. We urge you to consult your attorney about the specific situation and any legal questions you may have. Attorney advertising in some jurisdictions. © 2024 Leibowitz Law. All rights reserved. “Leibowitz Law” is a trade name of Leibowitz LLC.

Want to receive notifications?

To be notified when we post new Insights, please sign up for our email list. As industry thought leaders, Leibowitz Law Insights address developing issues at the intersection of law, regulation, technology and life sciences…